|
1
|
O'Donoghue ML, Glaser R, Cavender MA,
Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA,
Gutierrez JA, et al: Effect of losmapimod on cardiovascular
outcomes in patients hospitalized with acute myocardial infarction:
A randomized clinical trial. JAMA. 315:1591–1599. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prati F, Romagnoli E, Limbruno U,
Pawlowski T, Fedele S, Gatto L, Di Vito L, Pappalardo A, Ramazzotti
V, Picchi A, et al: Randomized evaluation of intralesion versus
intracoronary abciximab and aspiration thrombectomy in patients
with ST-elevation myocardial infarction: The COCTAIL II trial. Am
Heart J. 170:1116–1123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clemmensen P, Grieco N, Ince H, Danchi N,
Goedicke J, Ramos Y, Schmitt J, Goldstein P, et al: MULTIPRAC study
investigators: MULTInational non-interventional study of patients
with ST-segment elevation myocardial infarction treated with
PRimary Angioplasty and Concomitant use of upstream antiplatelet
therapy with prasugrel or clopidogrel-the European MULTIPRAC
registry. Eur Heart J Acute Cardiovasc Care. 4:220–229. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koltowski L, Koltowska-Haggstrom M,
Filipiak KJ, Kochman J, Golicki D, Pietrasik A, Huczek Z, Balsam P,
Scibisz A and Opolski G: Quality of life in patients with
ST-segment elevation myocardial infarction undergoing percutaneous
coronary intervention-radial versus femoral access (from the OCEAN
RACE Trial). Am J Cardiol. 114:516–521. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xian Y, Wang TY, McCoy LA, Effron MB,
Henry TD, Bach RG, Zettler ME, Baker BA, Fonarow GC and Peterson
ED: Association of discharge aspirin dose with outcomes after acute
myocardial infarction: Insights from the treatment with ADP
receptor inhibitors: Longitudinal assessment of treatment patterns
and events after acute coronary syndrome (TRANSLATE-ACS) study.
Circulation. 132:174–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aarsetøy H, Brügger-Andersen T, Hetland Ø,
Grundt H and Nilsen DW: Long term influence of regular intake of
high dose n-3 fatty acids on CD40-ligand, pregnancy-associated
plasma protein A and matrix metalloproteinase-9 following acute
myocardial infarction. Thromb Haemost. 95:329–336. 2006.PubMed/NCBI
|
|
7
|
Fan Q, Chen, Fang X, Lau WB, Xue L, Zhao
L, Zhang H, Liang YH, Bai X, Niu HY, et al: Aging might augment
reactive oxygen species (ROS) formation and affect reactive
nitrogen species (RNS) level after myocardial ischemia/reperfusion
in both humans and rats. Age (Dordr). 35:1017–1026. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lima-Neto LG, Hirata RD, Luchessi AD,
Silbiger VN, Cavichioli D, Dos Santos ES, Sousa AG, Sprovieri SR,
De Sousa EB Jr, Dos Santos FC, et al: Chlamydophila pneumonia and
increased TLR4 gene expression in leukocytes are associated with
acute myocardial infarction. J Biol Regul Homeost Agents.
28:449–460. 2014.PubMed/NCBI
|
|
9
|
Moreira DM, da Silva RL, Vieira JL, Fattah
T, Lueneberg ME and Gottschall CA: Role of vascular inflammation in
coronary artery disease: Potential of anti-inflammatory drugs in
the prevention of atherothrombosis. Inflammation and
anti-inflammatory drugs in coronary artery disease. Am J Cardiovasc
Drugs. 15:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi ZY, Liu Y, Dong L, Zhang B, Zhao M,
Liu WX, Zhang X and Yin XH: Cortistatin improves cardiac function
after acute myocardial infarction in rats by suppressing myocardial
apoptosis and endoplasmic reticulum stress. J Cardiovasc Pharmacol
Ther. Apr 18–2016.(Epub ahead of print).
|
|
11
|
Sheu JJ, Chua S, Sun CK, Chang LT, Yen CH,
Wu CJ, Fu M and Yip HK: Intra-coronary administration of
cyclosporine limits infarct size, attenuates remodeling and
preserves left ventricular function in porcine acute anterior
infarction. Int J Cardiol. 147:79–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lazou A, Iliodromitis EK, Cieslak D,
Voskarides K, Mousikos S, Bofilis E and Kremastinos DT: Ischemic
but not mechanical preconditioning attenuates ischemia/reperfusion
induced myocardial apoptosis in anaesthetized rabbits: The role of
Bcl-2 family proteins and ERK1/2. Apoptosis. 11:2195–2204. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Wang R, Wang Y, Peng R, Wu Y and
Yuan Y: Ginkgo biloba extract mitigates liver fibrosis and
apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax
signaling. Drug Des Devel Ther. 9:6303–6317. 2015.PubMed/NCBI
|
|
14
|
Zhu X, Li Z, Li C, Zhang J, Zou Z and Wang
J: Ginkgo biloba extract and aspirin synergistically attenuate
activated platelet-induced ROS production and LOX-1 expression in
human coronary artery endothelial cells. Phytomedicine. 20:114–119.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsai HY, Huang PH, Lin FY, Chen JS, Lin SJ
and Chen JW: Ginkgo biloba extract reduces high-glucose-induced
endothelial reactive oxygen species generation and cell adhesion
molecule expression by enhancing HO-1 expression via Akt/eNOS and
p38 MAP kinase pathways. Eur J Pharm Sci. 48:803–811. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bashar T and Akhter N: Study on oxidative
stress and antioxidant level in patients of acute myocardial
infarction before and after regular treatment. Bangladesh Med Res
Counc Bull. 40:79–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang CH, Sheu JJ, Tsai TH, Chua S, Chang
LT, Chang HW, Lee FY, Chen YL, Chung SY, Sun CK, et al: Effect of
tacrolimus on myocardial infarction is associated with
inflammation, ROS, MAP kinase and Akt pathways in mini-pigs. J
Atheroscler Thromb. 20:9–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen W, Spitzl A, Mathes D, Nikolaev VO,
Werner F, Weirather J, Špiranec K, Röck K, Fischer JW, Kämmerer U,
et al: Endothelial actions of ANP enhance myocardial inflammatory
infiltration in the early phase after acute infarction. Circ Res.
119:237–248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hedström E, Aström-Olsson K, Ohlin AK,
Ohlin H and Arheden H: Initial results of inflammatory response,
matrix remodeling, and reactive oxygen species following PCI in
acute ischemic myocardial injury in man. J Invasive Cardiol.
23:371–376. 2011.PubMed/NCBI
|
|
20
|
Li W, Luo Z, Liu X, Fu L, Xu Y, Wu L and
Shen X: Effect of Ginkgo biloba extract on experimental cardiac
remodeling. BMC Complement Altern Med. 15:2772015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ayça B, Sahin I, Kucuk SH, Akin F, Kafadar
D, Avşar M, Avci II, Gungor B, Okuyan E and Dinckal MH: Increased
transforming growth factor-β levels associated with cardiac adverse
events in hypertrophic cardiomyopathy. Clin Cardiol. 38:371–377.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Talasaz AH, Khalili H, Jenab Y, Salarifar
M, Broumand MA and Darabi F: N-Acetylcysteine effects on
transforming growth factor-β and tumor necrosis factor-α serum
levels as pro-fibrotic and inflammatory biomarkers in patients
following ST-segment elevation myocardial infarction. Drugs R D.
13:199–205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang X, Lv H, Gu Y, Wang X, Cao H, Tang Y,
Chen H and Huang C: Protective effect of lycopene on cardiac
function and myocardial fibrosis after acute myocardial infarction
in rats via the modulation of p38 and MMP-9. J Mol Histol.
45:113–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arabacilar P and Marber M: The case for
inhibiting p38 mitogen-activated protein kinase in heart failure.
Front Pharmacol. 6:1022015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matsumoto-Ida M, Takimoto Y, Aoyama T,
Akao M, Takeda T and Kita T: Activation of TGF-beta1-TAK1-p38 MAPK
pathway in spared cardiomyocytes is involved in left ventricular
remodeling after myocardial infarction in rats. Am J Physiol Heart
Circ Physiol. 290:H709–H715. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Q, Feng J, Wang J, Zhang X, Zhang D,
Zhu T, Wang W, Wang X, Jin J, Cao J, et al: Disruption of TAB1/p38α
interaction using a cell-permeable peptide limits myocardial
ischemia/reperfusion injury. Mol Ther. 21:1668–1677. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bliksøen M, Mariero LH, Torp MK, Baysa A,
Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G and Stensløkken
KO: Extracellular mtDNA activates NF-κB via toll-like receptor 9
and induces cell death in cardiomyocytes. Basic Res Cardiol.
111:422016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Haar L, Ren X, Liu Y, Koch SE, Goines J,
Tranter M, Engevik MA, Nieman M, Rubinstein J and Jones WK: Acute
consumption of a high-fat diet prior to ischemia-reperfusion
results in cardioprotection through NF-κB-dependent regulation of
autophagic pathways. Am J Physiol Heart Circ Physiol.
307:H1705–H1713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ding HS, Yang J, Chen P, Yang J, Bo SQ,
Ding JW and Yu QQ: The HMGB1-TLR4 axis contributes to myocardial
ischemia/reperfusion injury via regulation of cardiomyocyte
apoptosis. Gene. 527:389–393. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng M, Wei X, Wu Z, Li W, Li B, Zhen Y,
Chen J, Wang P and Fei Y: NF-κB-mediated induction of autophagy in
cardiac ischemia/reperfusion injury. Biochem Biophys Res Commun.
436:180–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
